(Q46883535)

English

Restriction endonuclease fingerprinting enhanced conformation sensitive gel electrophoresis (REF-CSGE) in the analysis of BRCA1 exon 11 mutations in a high-risk breast cancer cohort

scientific article published in June 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/12007222

Restriction endonuclease fingerprinting enhanced conformation sensitive gel electrophoresis (REF-CSGE) in the analysis of BRCA1 exon 11 mutations in a high-risk breast cancer cohort (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/12007222

Jeffrey N Weitzel

5

object named as

Jeffrey N Weitzel

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

author name string

Josef S Herzog

1

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/12007222

Erik M Jancis

2

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/12007222

Shidong Liao

3

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/12007222

George Somlo

4

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/12007222

publication date

1 June 2002

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/12007222

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/12007222

19

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/12007222

6

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/12007222

656-663

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/12007222

High-dose chemotherapy and stem-cell rescue in the treatment of high-risk breast cancer: prognostic indicators of progression-free and overall survival

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10091

21 January 2018

The genetic attributable risk of breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10091

21 January 2018

BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10091

21 January 2018

Detection of mutations in multi-exon genes: comparison of conformation sensitive gel electrophoresis and sequencing strategies with respect to cost and time for finding mutations

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10091

21 January 2018

Optimization of PCR and electrophoresis conditions enhances mutation analysis of the BRCA1 gene

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10091

21 January 2018

Bi-directional dideoxy fingerprinting (Bi-ddF): a rapid method for quantitative detection of mutations in genomic regions of 300-600 bp

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10091

21 January 2018

Identifiers

10.1002/HUMU.10091

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/12007222

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/12007222

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46883535&oldid=2136183990"